Como cada año, el curso de enfermedades neuromusculares que se realizará el 25, 26 y 27 de mayo en el Hospital de Sant Pau, reunirá a profesionales interesados en la patología neuromuscular.
Durante tres días intensos se impartirán clases sobre los grandes grupos de patología neuromuscular. Estas clases están realizadas por expertos nacionales e internacionales en cada tema. Los talleres se realizarán por la tarde, profundizando en aspectos más técnicos y pruebas diagnósticas fundamentales en estas patologías.
Como cada año, el curso de enfermedades neuromusculares que se realizará el 25, 26 y 27 de mayo en el Hospital de Sant Pau, reunirá a profesionales interesados en la patología neuromuscular.
Durante tres días intensos se impartirán clases sobre los grandes grupos de patología neuromuscular. Estas clases están realizadas por expertos nacionales e internacionales en cada tema. Los talleres se realizarán por la tarde, profundizando en aspectos más técnicos y pruebas diagnósticas fundamentales en estas patologías.
Artículo Completo
Desde la Unidad de Enfermedades Neuromusculares del Hospital de Sant Pau lamentamos comunicar la triste noticia del fallecimiento de la Dra Isabel Illa, fundadora y Directora de la Unidad, Catedrática de Neurología, pionera en el campo de las enfermedades neuromusculares en nuestro país, maestra y mentora de muchos de nosotros. DEP.
Desde la Unidad de Enfermedades Neuromusculares del Hospital de Sant Pau lamentamos comunicar la triste noticia del fallecimiento de la Dra Isabel Illa, fundadora y Directora de la Unidad, Catedrática de Neurología, pionera en el campo de las enfermedades neuromusculares en nuestro país, maestra y mentora de muchos de nosotros. DEP.
Artículo Completo
La preinscripción para el X curso de Formación en Enfermedades Neuromusculares ya está abierta.
Este curso gratuito que se celebra en el Hospital de la Santa Creu i Sant Pau vuelve a ser presencial, salvo imprevistos, y tendrá lugar los días 25, 26 y 27 de Mayo de 2022.
La preinscripción para el X curso de Formación en Enfermedades Neuromusculares ya está abierta.
Este curso gratuito que se celebra en el Hospital de la Santa Creu i Sant Pau vuelve a ser presencial, salvo imprevistos, y tendrá lugar los días 25, 26 y 27 de Mayo de 2022.
Artículo Completo
La Dra. Lorena Martín Aguilar, investigadora del Grupo de Enfermedades Neuromusculares del Instituto de Investigación del Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, ha sido reconocida con el Premio Richard A.C. Hughes en el marco de la reunión anual de la Peripheral Nerve Society.
La Dra. Lorena Martín Aguilar, investigadora del Grupo de Enfermedades Neuromusculares del Instituto de Investigación del Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, ha sido reconocida con el Premio Richard A.C. Hughes en el marco de la reunión anual de la Peripheral Nerve Society.
Artículo Completo
El pasado viernes 28 de mayo concluyó el IX Curso de Enfermedades Neuromusculares impulsado por la Unidad de Enfermedades Neuromusculares del Hospital de la Santa Creu i Sant Pau y que cuenta cada año con la colaboración de grandes profesionales de toda España en este campo de enfermedades. Un curso donde los asistentes profundizan de forma intensa en los conocimientos de estas enfermedades a través de clases tanto teóricas como prácticas.
El pasado viernes 28 de mayo concluyó el IX Curso de Enfermedades Neuromusculares impulsado por la Unidad de Enfermedades Neuromusculares del Hospital de la Santa Creu i Sant Pau y que cuenta cada año con la colaboración de grandes profesionales de toda España en este campo de enfermedades. Un curso donde los asistentes profundizan de forma intensa en los conocimientos de estas enfermedades a través de clases tanto teóricas como prácticas.
Artículo Completo
La Dra Montse Olivé ha sido galardonada con el premio Eduard Bertran Rubió de la Sociedad Catalana de Neurología. El premio se otorga a profesionales en reconocimiento a la excelencia en la trayectoria profesional y académica
La Dra Montse Olivé ha sido galardonada con el premio Eduard Bertran Rubió de la Sociedad Catalana de Neurología. El premio se otorga a profesionales en reconocimiento a la excelencia en la trayectoria profesional y académica
Artículo Completo
Después de una primera semana teórica, el pasado viernes 14 de Mayo se realizó la primera sesión en streaming donde los alumnos pudieron interactuar en directo con los profesionales en Enfermedades Neuromusculares.
Después de una primera semana teórica, el pasado viernes 14 de Mayo se realizó la primera sesión en streaming donde los alumnos pudieron interactuar en directo con los profesionales en Enfermedades Neuromusculares.
Artículo Completo
Con motivo del Día Nacional de la Miastenia Gravis la Asociación de pacientes AMES ha organizado una serie de actividades informativas para dar visibilidad a esta enfermedad.
La miastenia grave (MG) es una enfermedad neuromuscular poco frecuente que se caracteriza porque los pacientes tienen fatigabilidad y debilidad de los músculos voluntarios. La debilidad puede afectar cualquier músculo incluyendo músculos oculares, de las extremidades y músculos vitales, responsables de la función respiratoria, de la deglución y de la fonación.
Con motivo del Día Nacional de la Miastenia Gravis la Asociación de pacientes AMES ha organizado una serie de actividades informativas para dar visibilidad a esta enfermedad.
La miastenia grave (MG) es una enfermedad neuromuscular poco frecuente que se caracteriza porque los pacientes tienen fatigabilidad y debilidad de los músculos voluntarios. La debilidad puede afectar cualquier músculo incluyendo músculos oculares, de las extremidades y músculos vitales, responsables de la función respiratoria, de la deglución y de la fonación.
Artículo Completo
Eduard Gallardo ha sido nombrado jefe de grupo de la U762 CIBERER en el Hospital de Sant Pau de Barcelona en sustitución de Isabel Illa. Este equipo de investigación está especializado en enfermedades neuromusculares.
El Dr. Gallardo trabaja desde 1993 en el campo de las neuropatías desinmunes, miastenia, miopatías inflamatorias y distrofias musculares, y más específicamente en las disferlinopatías. Tiene más de 100 publicaciones (PubMed) en el campo de las enfermedades neuromusculares y ha sido investigador principal de 12 proyectos de investigación.
Eduard Gallardo ha sido nombrado jefe de grupo de la U762 CIBERER en el Hospital de Sant Pau de Barcelona en sustitución de Isabel Illa. Este equipo de investigación está especializado en enfermedades neuromusculares.
El Dr. Gallardo trabaja desde 1993 en el campo de las neuropatías desinmunes, miastenia, miopatías inflamatorias y distrofias musculares, y más específicamente en las disferlinopatías. Tiene más de 100 publicaciones (PubMed) en el campo de las enfermedades neuromusculares y ha sido investigador principal de 12 proyectos de investigación.
Artículo Completo
Debido a la alerta sanitaria mundial que se vive estos días ante la pandemia por SARS-COV2, un grupo de expertos mundiales en Miastenia Gravis ha desarrollado un documento de recomendaciones dirigidos a pacientes y médicos. En el documento adjunto encontraréis recomendaciones generales para pacientes con Miastenia Gravis y Síndrome de Eaton-Lambert, indicaciones para inicio de tratamiento y para pacientes en ensayo clínico.
Debido a la alerta sanitaria mundial que se vive estos días ante la pandemia por SARS-COV2, un grupo de expertos mundiales en Miastenia Gravis ha desarrollado un documento de recomendaciones dirigidos a pacientes y médicos. En el documento adjunto encontraréis recomendaciones generales para pacientes con Miastenia Gravis y Síndrome de Eaton-Lambert, indicaciones para inicio de tratamiento y para pacientes en ensayo clínico.
Artículo Completo
Quienes somos
Equipo Clínico
Equipo Investigación
Ricard Rojas García
MD PhD – Neurólogo Adjunto
Neurólogo
Luis Querol Gutiérrez
MD PhD – Neurólogo Adjunto
Neurólogo
Janina Turon i Sans
Neurofisióloga Adjunta
Neurofisióloga Adjunta
Montse Olivé
Neurofisióloga adjunta
Neurofisióloga adjunta
Elena Cortés Vicente
Neuróloga - Investigadora Post-doctoral
Neuróloga
Elba Pascual Goñi
Neuróloga - Investigadora predoctoral
Neuróloga
Lorena Martín Aguilar
Neuróloga e Investigadora pre-doctoral
Neuróloga e Investigadora pre-doctoral
Jorge Alonso Pérez
Neurólogo - Investigador predoctoral
Neurólogo - Investigador predoctoral
Rodrigo Álvarez Velasco
Neurólogo - Investigador predoctoral
Neurólogo - Investigador predoctoral
Francesc Pla Juncà
Coordinador del Registro español de Enfermedades Neuromusculares
Coordinador del Registro español de Enfermedades Neuromusculares
Concepción Escola
Enfermera Asistencial - Gestora de casos
Enfermera
Eduard Gallardo Vigo
PhD – Investigador Senior
Investigador Senior
Noemi de Luna Salvà
PhD – Investigadora post-doctoral CIBERER
Investigadora
Jordi Díaz Manera
MD PhD – Neurólogo Adjunto
Neurólogo
Xavier Suárez-Calvet
PhD – Investigador Post-doctoral
Investigador
Cinta Lleixà
Investigadora pre-doctoral
Investigadora pre-doctoral
David Reyes Leiva
Investigador en enfermedades neuromusculares
Investigador en enfermedades neuromusculares
Publicaciones
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis.
Neurol Neuroimmunol Neuroinflamm
21/06/2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Am J Pathol
21/05/2022
Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study.
Muscle Nerve
01/05/2022
RhoA/ROCK2 signalling is enhanced by PDGF-AA in fibro-adipogenic progenitor cells: implications for Duchenne muscular dystrophy.
J Cachexia Sarcopenia Muscle
01/04/2022
Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
J Oncol Pharm Pract
11/02/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
Ann Clin Transl Neurol
01/02/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL.
Clin Endocrinol (Oxf)
01/11/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
J Neurol Neurosurg Psychiatry
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
Comment to "Autoantibodies to cortactin and agrin in sera of patients with myasthenia gravis".
J Neuroimmunol
15/09/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
Clinical characteristics and outcomes of thymoma-associated myasthenia gravis.
Eur J Neurol
01/06/2021
Chronic inflammatory demyelinating polyneuropathy with hypertrophic nerves.
J Peripher Nerv Syst
01/06/2021
Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder.
Patient Prefer Adherence
12/04/2021
Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease.
Neuromuscul Disord
01/04/2021
A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
J Peripher Nerv Syst
01/03/2021
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Serum neurofilament light chain predicts long-term prognosis in Guillain-Barré syndrome patients.
J Neurol Neurosurg Psychiatry
05/11/2020
The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases.
Curr Opin Neurol
01/10/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy.
Neurobiol Aging
01/08/2020
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis.
Neurol Neuroimmunol Neuroinflamm
15/07/2020
COVID-19-associated ophthalmoparesis and hypothalamic involvement.
Neurol Neuroimmunol Neuroinflamm
25/06/2020
Antibodies to nodal/paranodal proteins in paediatric immune-mediated neuropathy.
Neurol Neuroimmunol Neuroinflamm
02/06/2020
Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy.
Ann Clin Transl Neurol
01/06/2020
Thigh Muscle Fat Infiltration Is Associated With Impaired Physical Performance Despite Remission in Cushing's Syndrome.
J Clin Endocrinol Metab
01/05/2020
Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
Neurologia (Engl Ed)
01/04/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Boundaries of chronic inflammatory demyelinating polyradiculoneuropathy.
J Peripher Nerv Syst
01/03/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Pain and the immune system: emerging concepts of IgG-mediated autoimmune pain and immunotherapies.
J Neurol Neurosurg Psychiatry
01/02/2020
APP-derived peptides reflect neurodegeneration in frontotemporal dementia.
Ann Clin Transl Neurol
01/12/2019
Autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy.
Curr Opin Neurol
01/10/2019
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Qual Life Res
01/08/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Identification of serum microRNAs as potential biomarkers in Pompe disease.
Ann Clin Transl Neurol
01/07/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.
J Neurol Neurosurg Psychiatry
01/05/2019
Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study.
J Neurol Neurosurg Psychiatry
01/11/2018
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials.
J Neurol Neurosurg Psychiatry
01/10/2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
Modified Yarham and Smith scores for pathogenicity assessment of mtDNA tRNA variants - Response.
Neuromuscul Disord
01/04/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Head and voice tremor improving with immunotherapy in an anti-NF155 positive CIDP patient.
Ann Clin Transl Neurol
07/03/2018
Corpus callosum agenesis, myopathy and pinpoint pupils: consider Stormorken syndrome.
Eur J Neurol
01/02/2018
MRI in sarcoglycanopathies: a large international cohort study.
J Neurol Neurosurg Psychiatry
01/01/2018
Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15.
J Neuroinflammation
16/11/2017
Early diagnosis of amyotrophic lateral sclerosis mimic syndromes: pros and cons of current clinical diagnostic criteria.
Amyotroph Lateral Scler Frontotemporal Degener
01/08/2017
RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Arthritis Res Ther
24/07/2017
The Clinical Outcome Study for dysferlinopathy: An international multicenter study.
Neurol Genet
04/08/2016
Does ability to walk reflect general functionality in inflammatory neuropathies?
J Peripher Nerv Syst
01/06/2016
Bethlem Myopathy Phenotypes and Follow Up: Description of 8 Patients at the Mildest End of the Spectrum.
J Neuromuscul Dis
27/05/2016
Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis.
Ann Clin Transl Neurol
27/04/2016
Longitudinal epitope mapping in MuSK myasthenia gravis: implications for disease severity.
J Neuroimmunol
15/02/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes.
Neuromuscul Disord
01/01/2016
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Rasch-built Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS(©) ).
J Peripher Nerv Syst
01/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Impairment measures versus inflammatory RODS in GBS and CIDP: a responsiveness comparison.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.
J Inherit Metab Dis
01/03/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
Neuromuscul Disord
01/12/2014
Comprehensive care of amyotrophic lateral sclerosis patients: a care model.
Arch Bronconeumol
01/12/2013
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy.
Orphanet J Rare Dis
23/10/2012
Trunk muscle involvement in late-onset Pompe disease: study of thirty patients.
Neuromuscul Disord
01/10/2012
Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
J Peripher Nerv Syst
01/06/2012
Unique post-exercise electrophysiological test results in a new Andersen-Tawil syndrome mutation.
Clin Neurophysiol
01/12/2011
Revised normative values for grip strength with the Jamar dynamometer.
J Peripher Nerv Syst
01/03/2011
Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal.
J Neurol Neurosurg Psychiatry
01/06/2010
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells.
J Clin Invest
01/01/2010
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Severe Guillain-Barré syndrome: sorting out the pathological hallmark in an electrophysiological axonal case.
J Peripher Nerv Syst
01/03/2009
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.
J Neuroimmunol
15/09/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance.
J Neuroimmunol
01/11/2001
Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.
J Neuropathol Exp Neurol
01/09/2001
Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Rev Neurol (Paris)
01/05/2001
HIV-associated polymyositis with life-threatening myocardial and esophageal involvement.
Arch Intern Med
10/05/1999
Dermatomyositis, polymyositis and inclusion body myositis: current concepts.
Rev Neurol (Paris)
01/01/1998
Antiganglioside antibodies in patients with acute polio and post-polio syndrome.
Ann N Y Acad Sci
25/05/1995
Post-polio syndrome: concepts in clinical diagnosis, pathogenesis, and etiology.
Adv Neurol
01/01/1991
Sensory neuropathy as the initial manifestation of primary biliary cirrhosis.
J Neurol Neurosurg Psychiatry
01/11/1989
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 982
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 983
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 983
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 984
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 984
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Am J Pathol
21/05/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
Ann Clin Transl Neurol
01/02/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Qual Life Res
01/08/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Bethlem Myopathy Phenotypes and Follow Up: Description of 8 Patients at the Mildest End of the Spectrum.
J Neuromuscul Dis
27/05/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
J Peripher Nerv Syst
01/06/2012
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance.
J Neuroimmunol
01/11/2001
Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Rev Neurol (Paris)
01/05/2001
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1026
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1027
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1027
Warning: Undefined array key 418 in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1028
Warning: Trying to access array offset on value of type null in /hosting/www/neuromuscularbcn.org/public/wp-content/themes/nmsp_v2/inc_nmsp_v2/functions_nmsp_v2.php on line 1028
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy.
J Cachexia Sarcopenia Muscle
01/06/2022
BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Am J Pathol
21/05/2022
Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
Ann Clin Transl Neurol
01/02/2022
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Clinical and Laboratory Features in Anti-NF155 Autoimmune Nodopathy.
Neurol Neuroimmunol Neuroinflamm
02/11/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Autoimmune nodopathies: treatable neuropathies beyond traditional classifications.
J Neurol Neurosurg Psychiatry
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
Novel Immunological and Therapeutic Insights in Guillain-Barré Syndrome and CIDP.
Neurotherapeutics
01/10/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Neuromuscul Disord
01/09/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering.
Neuromuscul Disord
01/08/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease.
Front Neurol
08/07/2021
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.
BMC Musculoskelet Disord
27/11/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Consistent improvement with eculizumab across muscle groups in myasthenia gravis.
Ann Clin Transl Neurol
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
J Cachexia Sarcopenia Muscle
01/08/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis.
Neurol Neuroimmunol Neuroinflamm
06/03/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
J Neurol Neurosurg Psychiatry
01/02/2020
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Qual Life Res
01/08/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Chronic inflammatory demyelinating polyneuropathy associated with contactin-1 antibodies in a child.
Neurol Neuroimmunol Neuroinflamm
24/07/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases.
Neuropathol Appl Neurobiol
01/06/2019
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
Ann Clin Transl Neurol
14/04/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Antibodies against cell adhesion molecules and neural structures in paraneoplastic neuropathies.
Ann Clin Transl Neurol
26/03/2018
Bethlem Myopathy Phenotypes and Follow Up: Description of 8 Patients at the Mildest End of the Spectrum.
J Neuromuscul Dis
27/05/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Amyotrophic lateral sclerosis: A higher than expected incidence in people over 80 years of age.
Amyotroph Lateral Scler Frontotemporal Degener
01/01/2016
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins.
Neurol Neuroimmunol Neuroinflamm
03/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
J Peripher Nerv Syst
01/09/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dried Blood Spot for Screening for Late-Onset Pompe Disease: A Spanish Cohort.
J Neuromuscul Dis
01/01/2015
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Int J Biochem Cell Biol
01/08/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Amyotrophic lateral sclerosis in Catalonia: a population based study.
Amyotroph Lateral Scler Frontotemporal Degener
01/05/2013
Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies.
J Peripher Nerv Syst
01/06/2012
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy.
J Neuropathol Exp Neurol
01/06/2010
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
01/11/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
Proteomics Clin Appl
01/04/2009
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Truncating mutations in C-terminal titin may cause more severe tibial muscular dystrophy (TMD).
Neuromuscul Disord
01/12/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype.
J Neurol Neurosurg Psychiatry
01/02/2008
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Nat Clin Pract Neurol
01/07/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
Dysferlin expression in monocytes: a source of mRNA for mutation analysis.
Neuromuscul Disord
01/01/2007
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
In vivo and in vitro dysferlin expression in human muscle satellite cells.
J Neuropathol Exp Neurol
01/10/2004
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Anti-titin antibodies are not associated with a specific thymoma histology.
J Neurol Neurosurg Psychiatry
01/02/2003
Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance.
J Neuroimmunol
01/11/2001
Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Rev Neurol (Paris)
01/05/2001